Saba Capital Management’s Pear Therapeutics, Inc. Class A Common Stock PEAR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-692,960
Closed -$6.89M 776
2021
Q3
$6.89M Hold
692,960
0.17% 150
2021
Q2
$6.85M Buy
692,960
+27,865
+4% +$276K 0.2% 109
2021
Q1
$6.38M Buy
+665,095
New +$6.38M 0.2% 87